Therapeutic Areas

Shire UK currently focuses on the following therapeutic areas: Alzheimer's Disease, Attention Deficit Hyperactivity Disorder (ADHD), Chronic Constipation, Fabry Disease, Essential Thrombocythaemia, Gaucher's Disease, Hereditary Angioedema, Hunter Syndrome, Chronic Kidney Disease, Ulcerative Colitis, and Seizures and Epilepsy.

Shire UK is a market leader in providing adjunctive therapies for patients with osteoporosis through our range of calcium-based supplements.

Shire UK brings the same focus and dedication to gastrointestinal and renal (kidney) diseases, with products for the treatment of mild to moderate ulcerative colitis, a type of inflammatory bowel disease, and a phosphate binder for use in some patients with chronic kidney disease.

Through the commitment of our employees, we are making a difference to patients, their families and carers, as well as to the medical community.